基本信息
浏览量:0
职业迁徙
个人简介
暂无内容
研究兴趣
论文共 68 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Khalid Al Sulaiman,Ohoud Aljuhani,Hadeel Alkofide, Manal A. Aljohani,Hisham A. Badreldin, Mahasen Al Harbi, Ghalia Aquil,Raghad Alhajaji,Rahaf A. Alqahtani, Alaa Babonji, Maha Altuwayr,Asma A. Alshehri,Mashael Alfaifi,Abdullah F. Alharthi,Mohammed Alzahrani,Tareq Al Sulaiman,Nasser Alqahtani,Walaa A. Alshahrani,Abdulmalik Al Katheri,Abdulkareem M. Albekairy
THROMBOSIS JOURNALno. 1 (2024)
Ohoud Aljuhani,Khalid Al Sulaiman,Abdulkareem M. Al Bekairy,Khalil Almajed, Mahasen Al Harbi,Abrar K. Thabit,Abdullah F. Alharthi,Namareq Aldardeer,Hisham A. Badreldin,Abdullah M. Alhammad,Ahmed O. Alenazi, Badr Alghamdi,Samiah Alsohimi,Mohammed Alshennawi,Abdulrahman I. Alshaya,Mohammed Alrashed,Omar A. Al Shaya,Ahmed Al-jedai
JOURNAL OF INFECTION AND PUBLIC HEALTH (2024): 68-75
Ohoud Aljuhani,Ghazwa B. Korayem,Ali F. Altebainawi, Daniah AlMohammady,Amjaad Alfahed, Elaf F. Altebainawi,Mohammed Aldhaeefi,Hisham A. Badreldin,Ramesh Vishwakarma,Faisal E. Almutairi,Abeer A. Alenazi,Thamer Alsulaiman,Rahaf Ali Alqahtani, Fahad Al Dhahri,Namareq Aldardeer,Ahmed O. Alenazi,Shmeylan Al Harbi,Raed Kensara,Mai Alalawi,Khalid Al Sulaiman
Current Research in Pharmacology and Drug Discovery (2024): 100179-100179
Hisham A. Badreldin,Nada Alsuhebany, Lama Alfehaid, Mohammed Alzahrani, Maha Aldoughaim,Abdullah M. Alrajhi, Jumanah Alsufyani, Dania Elsherif,Kanan Alshammari
crossref(2024)
Diabetes Research and Clinical Practice (2024): 111770-111770
Khalid Bin Saleh,Hisham A. Badreldin,Tariq Alqahtani,Nada Alsuhebany,Shuroug A. Alowais,Khalid Al Sulaiman,Mohammed Alrashed, Yara Alsaeed, Abdulrahman Alyousef, Rema Aldugiem,Ohoud Aljuhani,Naif Alharbi,Suliman Alghnam, Ahmed Almotiri,Hosam M. Zowawi,Nadiyah Alshehri,Sameera Al Johani,Mohammad Bosaeed
加载更多
作者统计
#Papers: 69
#Citation: 490
H-Index: 11
G-Index: 20
Sociability: 6
Diversity: 3
Activity: 27
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn